Strive, Inc. (ASST) KPIs and segments
Close on Nov 18, 2026Market cap $1.29BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Strive's business
Strive's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
Asset Management($M)3 | 1.51 | 1.35 | 1.50 | 1.49 | 1.42 | 1.04 | 0.98 | ||
Investment advisory fees($M) | 1.51 | 1.35 | 1.50 | 1.49 | 1.42 | 1.03 | 0.95 | ||
Other revenue($M) | 0 | 0 | 0 | 0 | 0.01 | 0.00 | 0.03 | ||
Medical device revenues($M) | 0 | 0 | 0 | ||||||
Medical Device($M)3 | 1.39 | 1.37 | 0 | 0 | |||||
Medical device revenues($M) | 1.39 | 1.37 | 0 | ||||||
Other revenue($M) | 0 | 0 | 0 | 0 | |||||
Investment advisory fees($M) | 0 | 0 | 0 | 0 | |||||
Corporate & Other($M)3 | 0.04 | 0.04 | 0.02 | 0.02 | 0 | 0 | 0 | ||
Other revenue($M) | 0.04 | 0.04 | 0.02 | 0.02 | 0 | 0 | 0 | ||
Investment advisory fees($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Medical device revenues($M) | 0 | 0 | 0 | ||||||
Investment advisory fees($M) | 1.51 | 1.35 | 1.50 | 1.49 | 1.42 | 1.03 | 0.95 | ||
Medical device revenues($M) | 1.39 | 1.37 | 0 | 0 | |||||
Other revenue($M) | 0.04 | 0.04 | 0.02 | 0.02 | 0.01 | 0.00 | 0.03 | ||
Asset Management($M) | -2.16 | -2.01 | -5.95 | -1.88 | -4.07 | -4.69 | -7.01 | ||
Medical Device($M) | -5.22 | -6.11 | 0 | 0 | |||||
Corporate & Other($M) | -251 | -305 | -235 | -1.81 | 0 | 0 | 0 | ||
Asset Management($M) | -2.16 | -2.00 | -5.94 | -1.86 | -3.75 | -4.12 | -6.80 | ||
Medical Device($M) | -4.95 | -5.91 | 0 | 0 | |||||
Corporate & Other($M) | -251 | -258 | -388 | -7.02 | 0 | 0 | 0 | ||
Asset Management($M) | -2.16 | -2.00 | -5.94 | -1.86 | -3.75 | -4.12 | -6.80 | ||
Medical Device($M) | -4.95 | -5.91 | 0 | 0 | |||||
Corporate & Other($M) | -251 | -258 | -388 | -7.02 | 0 | 0 | 0 | ||
Corporate & Other($M) | 1,358 | 1,081 | 744 | 791 | 0 | ||||
Medical Device($M) | 18.2 | 17.6 | 0 | ||||||
Asset Management($M) | 1.30 | 1.28 | 1.28 | 1.47 | 28.2 | ||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-10.
See a number that looks wrong?